Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHS.L Regulatory News (GHS)

  • There is currently no data for GHS

Net Asset Value Update

24 Nov 2021 13:13

RNS Number : 4846T
Gresham House Strategic PLC
24 November 2021
Β 

Gresham House Strategic plc

("GHS" or the "Company")

Net Asset Value Update

The Board of GHS announces that it has today been advised by its recently appointed investment manager, Harwood Capital LLP, that the realisation of the Augean proceeds, which gave rise to a gain of Β£18.8m, together with other recent profitable sales will give rise to a tax liability which was not provided for in the NAV calculations and that as a result, its weekly net asset values have been incorrectly stated since 30 July 2021, the date on which an offer for Augean was formally announced.

The net impact of the overstatement was approximately Β£1.3 million as at 19 November 2021 (approximately 2% of NAV), the date of the last NAV released by GHS. The amount is made up of a tax provision of approximately Β£1.6 million less an overpayment of management and performance fees to Gresham House Asset Management (GHS's former investment manager) of approximately Β£0.3m (inclusive of VAT), which the Board now intends to reclaim.

Whilst the Company has significant brought forward capital losses, changes to the tax legislation which became effective on 1 April 2020 limit the use of capital losses against realised gains to Β£5 million per year. Thereafter, 50 per. cent of realised gains are subject to corporation tax. The net effect is that realised gains over Β£5 million per annum are currently taxed at 9.5 per cent. and not zero as was previously the case.

Further, the Board has been advised that if the entire GHS portfolio was liquidated today at current market prices which follows the announcement of the proposed takeover of Universe Group yesterday and which will, if concluded give rise to a gain of Β£3 million, there would be an additional corporation tax liability of approximately Β£1.3 million (approximately 2% of NAV).

The Board is arranging for all the weekly NAV calculations to be recalculated since 30 July 2021 and they will be released to the market when this exercise is concluded.

A further announcement will be made in due course.

Β 

Enquiries:

Gresham House Strategic

Ken Lever, Senior Independent Director

+44 (0) 20 7220 0500

Β 

Harwood Capital LLP

Christopher Mills

+ 44 (0) 20 7640 3200

finnCap (Nominated Adviser and Joint Broker to GHS)

William Marle / Ed Frisby / Mark Whitfeld /Β Pauline Tribe

Β 

+44 (0) 20 7220 0500

Panmure Gordon (UK) LimitedΒ (Joint Broker to GHS)

Sapna Shah / Alex Collins

Β 

+44 (0) 20 7886 2500

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVDKQBDNBDDBDB
Date   Source Headline
18th Jul 201611:45 amRNSNAV Update
11th Jul 20163:26 pmRNSNAV Update
4th Jul 20163:06 pmRNSNAV Update
1st Jul 20163:14 pmRNSNAV Update
1st Jul 201611:10 amRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSPosting of Annual Report & Notice of AGM
27th Jun 20161:05 pmRNSNAV Update
23rd Jun 20167:00 amRNSPreliminary Results
20th Jun 20162:38 pmRNSNAV Update
14th Jun 20163:14 pmRNSHolding(s) in Company
13th Jun 20163:07 pmRNSNAV Update
6th Jun 201611:52 amRNSNAV Update
2nd Jun 20167:00 amRNSNotification of major interest in shares
2nd Jun 20167:00 amRNSHolding(s) in Company
1st Jun 20161:48 pmRNSNAV Update
31st May 20162:22 pmRNSNAV Update
23rd May 20163:24 pmRNSNAV Update
16th May 201611:11 amRNSNAV Update
9th May 201612:54 pmRNSNAV Update
3rd May 201612:23 pmRNSNAV Update
26th Apr 20163:35 pmRNSDirector/PDMR Shareholding
25th Apr 20164:24 pmRNSNAV Update
18th Apr 201610:44 amRNSNAV Update
13th Apr 20163:59 pmRNSDirector's Dealing
12th Apr 20166:03 pmRNSDirector's Dealing
12th Apr 20164:30 pmRNSDirector's Dealing
11th Apr 201611:04 amRNSNAV Update
4th Apr 20162:03 pmRNSNAV Update
1st Apr 201612:39 pmRNSNAV Update and Quarterly Factsheet
31st Mar 20167:00 amRNSHolding(s) in Company
29th Mar 20161:59 pmRNSNAV Update
21st Mar 201612:25 pmRNSNAV Update
14th Mar 20162:16 pmRNSNAV Update
7th Mar 201611:38 amRNSNAV Update
1st Mar 201611:42 amRNSNAV Update
29th Feb 201610:54 amRNSNAV Update
22nd Feb 201611:16 amRNSNAV Update
15th Feb 201612:05 pmRNSNAV Update
9th Feb 20165:01 pmRNSNotifcation of interests in shares
8th Feb 20163:01 pmRNSNAV Update
2nd Feb 20165:20 pmRNSHolding(s) in Company
1st Feb 20162:01 pmRNSNAV Update
25th Jan 20162:36 pmRNSNAV Update
18th Jan 20162:41 pmRNSNAV Update
11th Jan 20162:12 pmRNSNAV Update
7th Jan 20167:00 amRNSDirector Appointment
4th Jan 20162:00 pmRNSDirector's Dealing
4th Jan 201612:30 pmRNSNAV Update
29th Dec 201512:30 pmRNSNAV Update
21st Dec 20153:28 pmRNSNAV Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.